Primary malignant lymphoma of the trigeminal region treated with rapid infusion of high-dose MTX and radiation: Case report and review of the literature

Surgical Neurology

Volumn 60, Issue 4, 2003, Pages 343-348

  Kinoshita, Manabu ^a   Izumoto, Shuichi ^a   Oshino, Satoru ^a   Nonaka, Masahiro ^a   Moriuchi, Shusuke ^a   Maruno, Motohiko ^a   Yoshimine, Toshiki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Malignant lymphoma; Meckel's cave; Rapid high dose MTX therapy; Trigeminal neuralgia

Indexed keywords

METHOTREXATE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; HUMAN; HUMAN TISSUE; INFUSION; LYMPHOMA; MALE; NEURILEMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; TRIGEMINAL NERVE DISEASE; TUMOR BIOPSY;

EID: 0141849445     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(02)01046-7     Document Type: Article

References (18)

1. Abdel Aziz K.M., van Loveren H.R. Primary lymphoma of Meckel's cave mimicking trigeminal schwannoma case report . Neurosurgery. 44:1999;859-864.
2. Aho R., Ekfors T., Haltai M., Kalimo H. Pathogenesis of primary central nervous system invasion of malignant lymphoid cells into and within the brain parenchyma . Acta Neuropathol (Berl). 86:1993;71-76.
3. Blay J.Y., Conroy T., Chevreau C., et al. High-dose methotrexate for the treatment of primary cerebral lymphomas analysis of survival and late neurologic toxicity in a retrospective series . J Clin Oncol. 16:1998;864-871.
4. Brada M., Dearnaley D., Horwich A., Bloom H.J. Management of primary cerebral lymphoma with initial chemotherapy preliminary results and comparison with patients treated with radiotherapy alone . Int J Radiat Oncol Biol Phys. 18:1990;787-792.
5. Davies K.G., Cole G.C., Weeks R.D. Twenty-year survival following excision of primary CNS lymphoma without radiation therapy case report . Br J Neurosurg. 8:1994;487-491.
6. De Pena C.A., Lee Y.-Y., Van Tassel P. Lymphomatous involvement of the trigeminal nerve and Meckel cave CT and MR appearance . AJNR Am J Neuroradiol. 10:(Suppl 5):1989;S15-17.
7. DeAngelis L.M., Yahalom J., Heinemann M.-H., Cirrincione S., Thaler H.T., Krol G. Primary CNS lymphoma combined treatment with chemotherapy and radiotherapy . Neurology. 40:1990;80-86.
8. Delpassand E.S., Kirkpatrick J.B. Cavernous sinus syndrome as the presentation of malignant lymphoma a case report and review of the literature . Neurosurgery. 23:1988;501-504.
9. Eby N.L., Grufferman S., Flannelly C.M., Schold S.C. Jr, Vogel F.S., Burger P.C. Increasing incidence of primary brain lymphoma in the US. Cancer. 62:1988;2461-2465.
10. Freilich R.J., Delattre J.Y., Monjour A., DeAngelis L.M. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology. 46:1996;435-439.
11. Han M.H., Chang K.H., Kim I.O., Kim D.K., Han M.C. Non-Hodgkin lymphoma of the central skull base MR manifestations . J Comput Assist Tomogr. 17:1993;567-571.
12. Hayakawa T., Takakura K., Abe H., et al. Primary central nervous lymphoma in Japan a retrospective, co-operative study by CNS-lymphoma group in Japan . J Neurooncol. 19:1994;197-215.
13. Hiraga S., Arita N., Ohnishi T., et al. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphoma. J Neurosurg. 91:1999;221-230.
14. Hirsch W.L. Jr, Hryshko F.G., Sekhar L.N., et al. Comparison of MR imaging, CT, and angiography in evaluation of the enlarged cavernous sinus. Am J Radiol. 151:1988;1015-1023.
15. Julian J., Ferrer X., Drouillard J., Philippe J.C., Desbordes P. Cavernous sinus syndrome due to lymphoma. J Neurol Neurosurg Psychiatry. 47:1984;558-560.
16. Nakatomi H., Sasaki T., Kawamoto S., Fujimaki T., Furuya K., Kirino T. Primary cavernous sinus malignant lymphoma treated by gamma knife radiosurgery case report and review of the literature . Surg Neurol. 46:1996;272-279.
17. Neuwelt E.A., Goldman D.L., Dahlborg S.A., et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption prolonged survival and preservation of cognitive function . J Clin Oncol. 9:1991;1580-1590.
18. Roman-Goldstein S.M., Jones A., Delashaw J.B., McMenomey S., Neuwelt E.A. Atypical central nervous system lymphoma at the cranial base report of four cases . Neurosurgery. 43:1998;613-616.